Parexel: Increased revenue, increased staff in robust Q3
CRO Parexel announced an uptick in revenue for the third quarter of 2014, as well as a new company record for operating margin.
Archives for May 4, 2014
Bayer teams with Cenix in RNAi tech discovery deal
Bayer has inked a deal with preclinical CRO Cenix BioScience to use its genome-scale RNA interference (RNAi) platform to target an undisclosed disease.
Pfizer says manufacturing will stay in UK if it buys AstraZeneca
Pfizer will keep a “substantial” level of manufacturing in the UK if it takes over AstraZeneca, said the CEO in a letter to the country’s Prime Minister.
Icon and Parexel: Pfizer-AZ merger will bring more business for CROs
A mega-merger between Pfizer and AstraZeneca would bring increased business to CROs say Icon and Parexel, if past experiences are to go by.
Hospira: New Vizag plant online this year despite US FDA 483
Hospira says approval for its new manufacturing facility in India is still on track despite receiving a Form 483 form the US FDA with ten observations.